Exane Derivatives’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
$837K Sell
13,537
-4,847
-26% -$300K 0.48% 51
2022
Q1
$1.09M Buy
18,384
+3,636
+25% +$216K 0.31% 81
2021
Q4
$1.07M Buy
14,748
+586
+4% +$42.6K 0.26% 81
2021
Q3
$989K Buy
14,162
+9,521
+205% +$665K 0.24% 89
2021
Q2
$316K Sell
4,641
-1,201
-21% -$81.7K 0.07% 266
2021
Q1
$378K Buy
5,842
+493
+9% +$31.9K 0.11% 180
2020
Q4
$312K Sell
5,349
-15,592
-74% -$908K 0.09% 235
2020
Q3
$1.32M Sell
20,941
-11,900
-36% -$752K 0.38% 52
2020
Q2
$2.53M Buy
32,841
+26,103
+387% +$2.01M 0.68% 34
2020
Q1
$504K Hold
6,738
0.14% 114
2019
Q4
$432K Sell
6,738
-52,721
-89% -$3.38M 0.08% 178
2019
Q3
$3.77M Sell
59,459
-557
-0.9% -$35.3K 0.68% 29
2019
Q2
$4.05M Sell
60,016
-6,136
-9% -$414K 0.71% 26
2019
Q1
$4.3M Buy
+66,152
New +$4.3M 0.85% 23
2018
Q2
Sell
-4,527
Closed -$338K 653
2018
Q1
$338K Sell
4,527
-9,856
-69% -$737K 0.07% 175
2017
Q4
$1.03M Sell
14,383
-1,268
-8% -$90.8K 0.18% 90
2017
Q3
$1.27M Sell
15,651
-311
-2% -$25.2K 0.24% 67
2017
Q2
$1.13M Buy
15,962
+3,755
+31% +$266K 0.24% 80
2017
Q1
$829K Sell
12,207
-7,008
-36% -$476K 0.19% 90
2016
Q4
$1.38M Sell
19,215
-38,100
-66% -$2.73M 0.27% 62
2016
Q3
$4.53M Buy
57,315
+39,670
+225% +$3.14M 0.68% 38
2016
Q2
$1.47M Buy
17,645
+375
+2% +$31.3K 0.24% 64
2016
Q1
$1.59M Buy
17,270
+6,405
+59% +$588K 0.21% 59
2015
Q4
$1.1M Buy
10,865
+1,369
+14% +$139K 0.15% 68
2015
Q3
$932K Sell
9,496
-194,978
-95% -$19.1M 0.12% 77
2015
Q2
$23.9M Buy
204,474
+192,379
+1,591% +$22.5M 2.57% 5
2015
Q1
$1.19M Buy
12,095
+2,253
+23% +$221K 0.13% 78
2014
Q4
$928K Buy
+9,842
New +$928K 0.13% 84